SAN FRANCISCO, July 25, 2017 /PRNewswire/ -- Tueo Health, a digital health start-up company that has developed a
"Asthma is a costly chronic disease that affects more than 7 million children in the US alone," said Tueo Founder and CEO, Bronwyn Harris, MD. "Over half of asthma related direct healthcare costs are from hospital-based care that could be avoided by better asthma control."
"New methods of passive monitoring make real control of debilitating conditions possible, and Tueo Health is leading this effort in conditions of the lungs," said Fred Toney, CEO of Launchpad Digital Health. "With smart inhalers, we can now better measure dosing of drugs, but Tueo provides the critical information necessary on a daily basis to assess how the patient is responding."
Tueo Health has created an integrated solution that combines sensor-based nocturnal monitoring; personalized analytics based on physiologic data; a mobile app that delivers data and provides educational and clinical context; and an asthma coach that assists in self-management. Prompts and guidance are based on guidelines from the National Asthma Education and Prevention Program.
"As a parent of a child with asthma, it makes me sad that so many children are limited by the disease," said Harris, who is both a biomedical engineer and pediatric cardiologist. "We are leveraging technological advancements to create the data and tools families need to manage the condition and improve quality of life."
Tueo will use the financing to conduct a clinical study starting in September and drive continued application development and market positioning.
About Tueo Health
Tueo Health is a San Francisco-based company that is building a digital health solution to empower families to take better control of asthma management. The first Tueo solution is based on passive nocturnal monitoring, a mobile app, and targeted coaching and education. More information can be found at: www.tueohealth.com.
About Launchpad Digital Health
Launchpad Digital Health is the most active seed stage fund for digital health in the U.S. Its unique side-by-side immersion program includes more capital, more time and more intensity for its portfolio companies and their founders.
View original content:http://www.prnewswire.com/news-releases/tueo-health-oversubscribes-seed-round-to-support-clinical-study-and-growth-300492617.html
SOURCE Tueo Health
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All